Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman–Moore strain) manufactured in India

Lignende værker

• Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: Results of a randomized, open label, active-controlled trial in healthy adult volunteers in India
  af: Sudarshan, Mysore Kalappa, et al.
  Udgivet: (2012)
• Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis
  af: Ravish, Hardanahalli S, et al.
  Udgivet: (2014)
• Pre-exposure prophylaxis against rabies in children: Safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route
  af: Ravish, Haradanahalli S, et al.
  Udgivet: (2013)
• Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines when administered by intradermal route: Results of a metaanalysis
  af: Sudarshan, Mysore Kalappa, et al.
  Udgivet: (2010)
• Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases
  af: Narayana, Ashwath, et al.
  Udgivet: (2015)